CXCL8 and gastric cancer: In patients with gastric cancer of stages I, II, and III of the disease, an increase in IL-8 was observed compared to the control group and the group of patients at IV (p1–2 < 0.001, p1–3 < 0.001, p1–4 < 0.001).